Waldencast (NASDAQ:WALD) Now Covered by TD Cowen

Investment analysts at TD Cowen started coverage on shares of Waldencast (NASDAQ:WALD) in a report released on Monday,Briefing.com Automated Import reports. The brokerage set a “hold” rating and a $4.30 price target on the stock. TD Cowen’s price target points to a potential upside of 10.54% from the company’s previous close.

WALD has been the subject of several other reports. DA Davidson boosted their target price on Waldencast from $7.25 to $7.50 and gave the company a “buy” rating in a research note on Wednesday, December 4th. Canaccord Genuity Group upped their price objective on shares of Waldencast from $5.00 to $6.00 and gave the company a “buy” rating in a research note on Friday, November 22nd. Telsey Advisory Group reaffirmed an “outperform” rating and set a $6.00 price target on shares of Waldencast in a research report on Monday, November 18th. Finally, Canaccord Genuity Group started coverage on Waldencast in a report on Friday, October 25th. They set a “buy” rating and a $5.00 target price for the company. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, Waldencast currently has an average rating of “Moderate Buy” and a consensus price target of $5.76.

Waldencast Trading Up 4.0 %

NASDAQ:WALD opened at $3.89 on Monday. The business has a 50 day moving average of $3.43 and a 200 day moving average of $3.52. Waldencast has a 1-year low of $2.40 and a 1-year high of $12.00. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.78 and a current ratio of 1.47.

Institutional Trading of Waldencast

Institutional investors and hedge funds have recently bought and sold shares of the company. Barclays PLC increased its position in shares of Waldencast by 301.4% during the third quarter. Barclays PLC now owns 32,436 shares of the company’s stock valued at $117,000 after acquiring an additional 24,355 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. increased its holdings in shares of Waldencast by 293.9% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,854 shares of the company’s stock worth $25,000 after purchasing an additional 5,114 shares in the last quarter. Catalina Capital Group LLC bought a new position in Waldencast during the third quarter valued at approximately $58,000. Milestones Administradora de Recursos Ltda. grew its position in Waldencast by 10.0% in the 3rd quarter. Milestones Administradora de Recursos Ltda. now owns 2,200,000 shares of the company’s stock worth $8,008,000 after purchasing an additional 200,000 shares during the period. Finally, McAdam LLC purchased a new stake in Waldencast during the 3rd quarter valued at $62,000. 41.97% of the stock is currently owned by institutional investors.

About Waldencast

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.